longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Evercore ISI Sticks to Its Buy Rating for Definium Therapeutics (DFTX)

Tip Ranks
Aug 10, 2026 at 12:45 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Evercore ISI analyst maintained a Buy rating on Definium Therapeutics today and set a price target of $53.00.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks In a report released on August 7, Jefferies also maintained a Buy rating on the stock with a $65.00 price target.

Evercore ISI analyst maintained a Buy rating on Definium Therapeutics today and set a price target of $53.00.

Claim 55% Off TipRanks

  • Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
  • Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

In a report released on August 7, Jefferies also maintained a Buy rating on the stock with a $65.00 price target.

Login to unlock474characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Definium Therapeutics

Definium Therapeutics

USDFTX

+3.07%

Evercore

Evercore

USEVR

Jefferies Financial

Jefferies Financial

USJEF

LongbridgeAI